tag:blogger.com,1999:blog-9551150.post7122030223854923341..comments2024-03-28T01:27:23.408-04:00Comments on Health Care Renewal: Criticism of Surrogate Endpoints in Whose Interests?Roy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger5125tag:blogger.com,1999:blog-9551150.post-48246831141257699922008-06-25T02:00:00.000-04:002008-06-25T02:00:00.000-04:00Although I realize I'm late to the party, I just w...Although I realize I'm late to the party, I just wanted to point out that I noted Thornton's lack of disclosure in a WSJ op-ed way back in <A HREF="http://venturebeat.com/2007/06/06/patients-ceos-and-ideologues-vs-evidence-based-medicine/" REL="nofollow">June of last year in a VentureBeat post</A>. (It's a long post, so search on "Thornton" if you're interested; at the time he was complaining David Hamiltonhttps://www.blogger.com/profile/08966183699278412598noreply@blogger.comtag:blogger.com,1999:blog-9551150.post-12971115809261121622008-06-04T13:51:00.000-04:002008-06-04T13:51:00.000-04:00Provenge and Our F.D.A.’s Etiology For Not Being ...Provenge and Our F.D.A.’s Etiology For Not Being Approved<BR/><BR/>Terminal patients are those who are not expected to live due to usually illness such as advanced prostate cancer (cT3). If the patient has 6 months or less to live, those patients are considered terminally ill. Regardless, if a patient is terminal, they are without a cure or tolerable treatment for their illness. Since such Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-23344060237843675962008-06-03T08:02:00.000-04:002008-06-03T08:02:00.000-04:00For some time I have felt that a large part of med...For some time I have felt that a large part of medicine reflects the corporate culture of pharma. Half truths, buried information, and other marketing "tricks" are the hallmark of this industry.<BR/><BR/>This point was made once again in the June 2 WSJ Health Blog posting on TriCor by Abbott Labs. I will let the doctors discuss the medical issues. The jest of the article is that Teva has tried Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-86299119164897490172008-06-02T20:35:00.000-04:002008-06-02T20:35:00.000-04:00Sen. Grassley's statement:http://www.senate.gov/~f...Sen. Grassley's statement:<BR/><BR/>http://www.senate.gov/~finance/press/Gpress/2008/prg053008d.pdfAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-43744092893002692862008-06-02T17:24:00.000-04:002008-06-02T17:24:00.000-04:00from today's WSJ, Sen. Grassley's response:It does...from today's WSJ, Sen. Grassley's response:<BR/><BR/>It doesn't help cancer patients or anyone else who has to rely on groundbreaking pharmaceuticals for a drug company executive with a financial stake in Food and Drug Administration approvals to attack independent review of the FDA ("Grassley's War on Cancer Patients," op-ed, May 29). The commentary by Mark Thornton, Senior VP of Product Anonymousnoreply@blogger.com